SCHEMBL21974572

SCHEMBL21974572

C=C(C)c1cccc(C(C)(C)NC(=O)OCCCC)c1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
SMN1; SMN2 Q16637 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
MAPT P10636 2/20 0.52
LMNA P02545 2/20 0.52
TSHR P16473 2/20 0.52
HTT P42858 2/20 0.52
KDM4E B2RXH2 1/20 0.52
HPGD P15428 1/20 0.51
RAB9A P51151 1/20 0.51
GAA P10253 1/20 0.50
ALPL P05186 1/20 0.49
GLA P06280 1/20 0.49
ALPI P09923 1/20 0.49
ALPG P10696 1/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13144159 0.95 SMN1; SMN2 (0.52) ALDH1A1SMN1; SMN2L3MBTL1MAPTLMNA
SCHEMBL14275017 0.95 SMN1; SMN2 (0.52) ALDH1A1SMN1; SMN2L3MBTL1MAPTLMNA
SCHEMBL9039724 0.94 L3MBTL1 (0.56) ALDH1A1SMN1; SMN2L3MBTL1MAPTLMNA
SCHEMBL9039198 0.94 L3MBTL1 (0.56) ALDH1A1SMN1; SMN2L3MBTL1MAPTLMNA
SCHEMBL9038998 0.93 L3MBTL1 (0.55) ALDH1A1SMN1; SMN2L3MBTL1MAPTLMNA
SCHEMBL21914618 0.93 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2L3MBTL1MAPTLMNA
SCHEMBL9041007 0.93 L3MBTL1 (0.55) ALDH1A1SMN1; SMN2L3MBTL1MAPTLMNA
SCHEMBL8050704 0.91 L3MBTL1 (0.58) ALDH1A1SMN1; SMN2L3MBTL1MAPTLMNA
SCHEMBL17528571 0.91 L3MBTL1 (0.53) ALDH1A1SMN1; SMN2L3MBTL1MAPTLMNA
SCHEMBL14275041 0.91 HTT (0.54) ALDH1A1SMN1; SMN2L3MBTL1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250353938-A1 DYNAMICALLY CROSSLINKED POLYOLEFIN PRODUCED THROUGH A POST-REACTOR PROCESS WITH A DYNAMIC DISULFIDE CROSSLINKER BRASKEM AMERICA INC (US) 2025-11-20 US claimed
US-20250346695-A1 ETHYLENE BASED CO/TERPOLYMERS CONTAINING A HIGH PURITY -S-S- BASED DYNAMIC CROSSLINKER TO PRODUCE AN IN-REACTOR DYNAMIC MATERIAL BRASKEM AMERICA INC (US) 2025-11-13 US claimed
WO-2025235568-A1 ETHYLENE BASED CO/TERPOLYMERS CONTAINING A HIGH PURITY -S-S- BASED DYNAMIC CROSSLINKER TO PRODUCE AN IN-REACTOR DYNAMIC MATERIAL BRASKEM AMERICA, INC. (US) 2025-11-13 WO claimed
US-20250243302-A1 FREE RADICAL ETHYLENE/TERPENE COPOLYMERS BRASKEM S.A. (BR) 2025-07-31 US claimed
WO-2025129179-A1 FREE RADICAL ETHYLENE/TERPENE COPOLYMERS BRASKEM S.A. (BR) 2025-06-19 WO claimed
EP-4486823-A1 OPEN CELL POLYMER FOAM COMPOSITION WITH TUNABLE TORTUOSITY AND METHOD OF MAKING THE SAME Braskem S.A. (BR) 2025-01-08 EP claimed
WO-2023161726-A1 OPEN CELL POLYMER FOAM COMPOSITION WITH TUNABLE TORTUOSITY AND METHOD OF MAKING THE SAME BRASKEM S.A. (BR) 2023-08-31 WO claimed
US-20260075963-A1 TRIGGERABLE ENCAPSULANT MATERIAL FOR PHOTOVOLTAICS, PHOTOVOLTAIC MODULE, AND METHOD OF PRODUCING TRIGGERABLE ENCAPSULANT MATERIAL BRASKEM AMERICA INC (US) 2026-03-12 US disclosed
US-20250353938-A1 DYNAMICALLY CROSSLINKED POLYOLEFIN PRODUCED THROUGH A POST-REACTOR PROCESS WITH A DYNAMIC DISULFIDE CROSSLINKER BRASKEM AMERICA INC (US) 2025-11-20 US disclosed
US-20250346695-A1 ETHYLENE BASED CO/TERPOLYMERS CONTAINING A HIGH PURITY -S-S- BASED DYNAMIC CROSSLINKER TO PRODUCE AN IN-REACTOR DYNAMIC MATERIAL BRASKEM AMERICA INC (US) 2025-11-13 US disclosed
WO-2025235568-A1 ETHYLENE BASED CO/TERPOLYMERS CONTAINING A HIGH PURITY -S-S- BASED DYNAMIC CROSSLINKER TO PRODUCE AN IN-REACTOR DYNAMIC MATERIAL BRASKEM AMERICA, INC. (US) 2025-11-13 WO disclosed
US-20250243302-A1 FREE RADICAL ETHYLENE/TERPENE COPOLYMERS BRASKEM S.A. (BR) 2025-07-31 US disclosed
WO-2025129179-A1 FREE RADICAL ETHYLENE/TERPENE COPOLYMERS BRASKEM S.A. (BR) 2025-06-19 WO disclosed
WO-2022074237-A1 COMPOSITION COMPRISING AT LEAST ONE ORGANIC PEROXIDE AND AT LEAST ONE SULFUR-CONTAINING COMPOUND FOR CROSSLINKING POLYMERS IN THE PRESENCE OF OXYGEN ARKEMA FRANCE (FR) 2022-04-14 WO disclosed
US-20220106454-A1 ULTRASOFT EVA FOAM FORMULATION AND METHODS THEREOF BRASKEM S.A. (BR) 2022-04-07 US disclosed
US-20220106472-A1 EVA COMPOSITIONS FOR FOOTWEAR BRASKEM S.A. (BR) 2022-04-07 US disclosed
WO-2022069949-A1 ULTRASOFT EVA FOAM FORMULATION AND METHODS THEREOF BRASKEM S.A. (BR) 2022-04-07 WO disclosed
US-11267959-B2 Bio-based EVA compositions and articles and methods thereof BRASKEM S.A. (BR) 2022-03-08 US disclosed
US-20220056275-A1 SILICON- AND ZINC-CONTAINING COUPLING AGENT FOR CELLULOSIC MATERIAL-POLYMER COMPOSITES ARKEMA INC. 2022-02-24 US disclosed
US-20200142302-A1 CURABLE COMPOSITION, CURED PRODUCT, COLOR FILTER, METHOD FOR PRODUCING COLOR FILTER, SOLID-STATE IMAGING ELEMENT, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2020-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260075963-A1 TRIGGERABLE ENCAPSULANT MATERIAL FOR PHOTOVOLTAICS, PHOTOVOLTAIC MODULE, AND METHOD OF PRODUCING TRIGGERABLE ENCAPSULANT MATERIAL YWHAZ, RAD51, LBR ALDH1A1 4066/4885SMN1; SMN2 4124/4885L3MBTL1 2759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.